Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

anfarm hellas s.a. - caspofungin acetat -

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

anfarm hellas s.a. - caspofungin acetat -

Europäische Union - Deutsch - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunsuppressiva - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Europäische Union - Deutsch - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimethylfumarat - multiple sklerose, schubförmig-remittierender - immunsuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Europäische Union - Deutsch - EMA (European Medicines Agency)

accord healthcare s.l.u. - leuprorelin mesilate - prostata-neoplasmen - endokrine therapie - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Europäische Union - Deutsch - EMA (European Medicines Agency)

theramex ireland limited - linzagolix choline - leiomyom - hormone und analoga der hypophyse und des hypothalamus - yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

Europäische Union - Deutsch - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - brustgeschwulste - endokrine therapie - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

actavis group ptc ehf - olanzapin - olanzapin

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

drossapharm arzneimittel handelsgesellschaft mbh (8011747) - magnesiumsulfat-heptahydrat - konzentrat zur herstellung einer infusionslösung - teil 1 - konzentrat zur herstellung einer infusionslösung; magnesiumsulfat-heptahydrat (12538) 5 gramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

drossapharm arzneimittel handelsgesellschaft mbh (8011747) - magnesiumsulfat-heptahydrat - injektionslösung - teil 1 - injektionslösung; magnesiumsulfat-heptahydrat (12538) 1 gramm